Clinical Trial Update: Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease

View source ↗

Summary

A completed clinical trial from the University of Leipzig evaluating non-invasive liver screening as a risk assessment tool for coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of Leipzig | Conditions: Coronary Disease, Non-alcoholic Fatty Liver Disease | Status: COMPLETED